科研工作:

2016/05-至今，西北工业大学，生命学院，讲师2013/08-2016/04，第四军医大学，第二附属医院，主管药师2014/08-2015/10，加州大学戴维斯分校，博士后 [1] JosephL. Jilek#, Ye Tian#,Ai-Ming Yu*, Effects of MicroRNA-34a on the Pharmacokinetics ofCytochrome P450 Probe Drugs in Mice, Drug Metab Dispos, March 2, 2017, dmd.116.074344DOI: https://doi.org/10.1124/dmd.116.074344[2] Ye Tian, Shuijie Shen, Yan Jiang, QiShen, Su Zeng*, Jiang Zheng*, CYP3A5 mediatesbioactivation and cytotoxicity of tetrandrine, Arch Toxicol, 2016, 90(7): 1737-1748[3 Ye Tian, Yicong Bian, Yan Jiang, SainanQian, Aiming Yu, Su Zeng*, Interplay of Breast Cancer ResistanceProtein (BCRP) and metabolizing enzymes, Curr Drug Metab, 2015, 16(10): 877-893[4] Ye Tian, Sainan Qian, Yan Jiang, QiShen, Jiang Zheng, Hui Zhou*, Su Zeng*, The interactionbetween human breast cancer resistance protein (BCRP) and five bisbenzylisoquinolinealkaloids, Int J Pharmaceut, 2013, 453(2): 371-379[5] Ye Tian#, Ying He#,Haihong Hu, Lu Wang, Su Zeng*, Determination of theenantioselectivity of six chiral aryloxy aminopropanol drugs transport acrossCaco-2 cell monolayers, Acta Pharmaceutica Sinica B, 2012, 2(2): 168–173[6] 田野，屈伯宣，姚艳，曾苏*，LLC-PK1/BCRP细胞系的建立及其生物学特征，药学学报，2012，47(12)：1599-1604

教育背景:

2008/09-2013/06，浙江大学，药物化学，博士2010/11-2011/12，美国华盛顿大学，联合培养博士研究生2004/09-2008/06，浙江大学，药学，学士学位